SEC Form 4 · accession 0001193125-26-330506

Apnimed, Inc. · APMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Lawrence G. Miller

Director

Period of report

Aug 3, 2026

Accepted (ET)

Aug 3, 2026 · 4:01 pm EDT

Rule 10b5-1 plan

box not checked

Issuer CIK

0001745648

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Class A Common Stock^F1,F2	Aug 3, 2026	D	92,431	—	D	0	I	By Lawrence G. Miller Irrevocable Family Trust
Common Stock^F1,F2	Aug 3, 2026	A	92,431	—	A	92,431	I	By Lawrence G. Miller Irrevocable Family Trust
Common Stock^F3,F2	Aug 3, 2026	C	10,845	—	A	103,276	I	By Lawrence G. Miller Irrevocable Family Trust
Class A Common Stock^F1,F2	Aug 3, 2026	D	88,954	—	D	0	I	By Kathleen W. Miller Irrevocable Trust
Common Stock^F1,F2	Aug 3, 2026	A	88,954	—	A	88,954	I	By Kathleen W. Miller Irrevocable Trust
Class A Common Stock^F1,F2	Aug 3, 2026	D	88,954	—	D	0	I	By James S. Miller Irrevocable Trust
Common Stock^F1,F2	Aug 3, 2026	A	88,954	—	A	88,954	I	By James S. Miller Irrevocable Trust
Class A Common Stock^F1,F2	Aug 3, 2026	D	88,954	—	D	0	I	By David G. Miller Irrevocable Trust
Common Stock^F1,F2	Aug 3, 2026	A	88,954	—	A	88,954	I	By David G. Miller Irrevocable Trust
Class A Common Stock^F1,F2	Aug 3, 2026	D	88,954	—	D	0	I	By Ellen K. Williams Irrevocable Family Trust
Common Stock^F1,F2	Aug 3, 2026	A	88,954	—	A	88,954	I	By Ellen K. Williams Irrevocable Family Trust

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Preferred Stock^F2,F1	—	Aug 3, 2026	C	10,845	D	—	—	Common Stock	10,845	0	I
Stock Option (Right to Buy)^F4	$1.00	Aug 3, 2026	D	688,042	D	—	Jan 29, 2029	Class A Common Stock	688,042	0	D
Stock Option (Right to Buy)^F4	$1.00	Aug 3, 2026	A	688,042	A	—	Jan 29, 2029	Common Stock	688,042	688,042	D
Stock Option (Right to Buy)^F4	$1.00	Aug 3, 2026	D	98,843	D	—	Jan 28, 2030	Class A Common Stock	98,843	0	D
Stock Option (Right to Buy)^F4	$1.00	Aug 3, 2026	A	98,843	A	—	Jan 28, 2030	Common Stock	98,843	98,843	D
Stock Option (Right to Buy)^F4	$1.06	Aug 3, 2026	D	302,541	D	—	Mar 31, 2030	Class A Common Stock	302,541	0	D
Stock Option (Right to Buy)^F4	$1.06	Aug 3, 2026	A	302,541	A	—	Mar 31, 2030	Common Stock	302,541	302,541	D
Stock Option (Right to Buy)^F4	$2.74	Aug 3, 2026	D	333,580	D	—	Jun 14, 2032	Class A Common Stock	333,580	0	D
Stock Option (Right to Buy)^F4	$2.74	Aug 3, 2026	A	333,580	A	—	Jun 14, 2032	Common Stock	333,580	333,580	D
Stock Option (Right to Buy)^F5	$4.00	Aug 3, 2026	D	333,580	D	—	Dec 22, 2032	Class A Common Stock	333,580	0	D
Stock Option (Right to Buy)^F5	$4.00	Aug 3, 2026	A	333,580	A	—	Dec 22, 2032	Common Stock	333,580	333,580	D
Stock Option (Right to Buy)^F6	$4.87	Aug 3, 2026	D	333,580	D	—	Mar 13, 2034	Class A Common Stock	333,580	0	D
Stock Option (Right to Buy)^F6	$4.87	Aug 3, 2026	A	333,580	A	—	Mar 13, 2034	Common Stock	333,580	333,580	D
Stock Option (Right to Buy)^F4	$8.88	Aug 3, 2026	D	59,303	D	—	Jul 14, 2035	Class A Common Stock	59,303	0	D
Stock Option (Right to Buy)^F4	$8.88	Aug 3, 2026	A	59,303	A	—	Jul 14, 2035	Common Stock	59,303	59,303	D
Stock Option (Right to Buy)^F7	$8.88	Aug 3, 2026	D	25,574	D	—	Sep 19, 2035	Class A Common Stock	25,574	0	D
Stock Option (Right to Buy)^F7	$8.88	Aug 3, 2026	A	25,574	A	—	Sep 19, 2035	Common Stock	25,574	25,574	D
Stock Option (Right to Buy)^F8	$8.15	Aug 3, 2026	D	74,128	D	—	Jun 1, 2036	Class A Common Stock	74,128	0	D
Stock Option (Right to Buy)^F8	$8.15	Aug 3, 2026	A	74,128	A	—	Jun 1, 2036	Common Stock	74,128	74,128	D

Explanation of responses

F1Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock.
F2The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose.
F3Immediately prior to the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted on a one-for-one basis into shares of the Issuer's Class A Common Stock. The Series A Preferred Stock has no expiration date.
F4100% of the shares subject to the option are fully vested.
F525% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 22, 2022, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
F625% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 21, 2023, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
F725% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after September 17, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
F8The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 24 months after June 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.